News
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
FluMist is the only nasal vaccine approved in the U.S. It’s administered as two spritzes—one in each nostril—and stimulates ...
AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results